SCHEMBL755011

SCHEMBL755011

CCOc1c(OCC)c2ccccc2c2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
KDM4E B2RXH2 1/20 0.48
MAPK1 P28482 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
MAPT P10636 2/20 0.44
NQO1 P15559 1/20 0.43
LTA4H P09960 1/20 0.43
PTGER4 P35408 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
MPO P05164 2/20 0.40
SLC2A1 P11166 2/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
ELANE P08246 1/20 0.39
RELA Q04206 1/20 0.39
ATM Q13315 1/20 0.38
GABRP O00591 1/20 0.38
GABRD O14764 1/20 0.38
GABRA1 P14867 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29366895 0.92 ALDH1A1 (0.50) ALDH1A1KDM4EMAPK1SMN1; SMN2MAPT
SCHEMBL51657 0.92 ALDH1A1 (0.50) ALDH1A1KDM4EMAPK1SMN1; SMN2MAPT
SCHEMBL23271679 0.85 ALDH1A1 (0.44) ALDH1A1KDM4EMAPK1SMN1; SMN2MAPT
SCHEMBL30003317 0.85 ALDH1A1 (0.44) ALDH1A1KDM4EMAPK1SMN1; SMN2MAPT
SCHEMBL1127721 0.84 MAPT (0.42) ALDH1A1KDM4EMAPK1SMN1; SMN2MAPT
SCHEMBL30660757 0.83 ALDH1A1 (0.42) ALDH1A1KDM4EMAPK1SMN1; SMN2MAPT
SCHEMBL1127926 0.83 ALDH1A1 (0.42) ALDH1A1KDM4EMAPK1SMN1; SMN2MAPT
SCHEMBL23271850 0.83 ALDH1A1 (0.68) ALDH1A1KDM4EMAPK1SMN1; SMN2MAPT
SCHEMBL17189613 0.81 ALDH1A1 (0.41) ALDH1A1KDM4EMAPK1SMN1; SMN2MAPT
SCHEMBL27933306 0.81 MAPT (0.37) ALDH1A1KDM4EMAPK1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12624392-B2 Molecular array generation using photoresist 10X GENOMICS, INC. (US) 2026-05-12 US disclosed
EP-4516394-A2 HIGH DEFINITION MOLECULAR ARRAY FEATURE GENERATION USING PHOTORESIST 10x Genomics, Inc. (US) 2025-03-05 EP disclosed
EP-4481059-A2 MOLECULAR ARRAY GENERATION USING PHOTORESIST 10x Genomics, Inc. (US) 2024-12-25 EP disclosed
EP-4405094-B1 HIGH DEFINITION MOLECULAR ARRAY FEATURE GENERATION USING PHOTORESIST 10X GENOMICS INC (US) 2024-12-18 EP disclosed
EP-4271511-B1 MOLECULAR ARRAY GENERATION USING PHOTORESIST 10X GENOMICS INC (US) 2024-10-09 EP disclosed
EP-4405094-A1 HIGH DEFINITION MOLECULAR ARRAY FEATURE GENERATION USING PHOTORESIST 10X Genomics, Inc. (US) 2024-07-31 EP disclosed
US-20240167077-A1 COVALENT ATTACHMENT OF SPLINT OLIGONUCLEOTIDES FOR MOLECULAR ARRAY GENERATION USING LIGATION 10X GENOMICS, INC. (US) 2024-05-23 US disclosed
US-20240076656-A1 HIGH DEFINITION MOLECULAR ARRAY FEATURE GENERATION USING PHOTORESIST 10X GENOMICS, INC. (US) 2024-03-07 US disclosed
US-20240060127-A1 METHODS AND SYSTEMS FOR LIGHT-CONTROLLED SURFACE PATTERNING USING PHOTOMASKS 10X GENOMICS, INC. 2024-02-22 US disclosed
WO-2024006827-A1 METHODS AND SYSTEMS FOR LIGHT-CONTROLLED SURFACE PATTERNING USING PHOTOMASKS 10X GENOMICS, INC. (US) 2024-01-04 WO disclosed
EP-1752463-A1 NOVEL FLUORINATED ALKYLFLUOROPHOSPHORIC ACID SALT OF ONIUM AND TRANSITION METAL COMPLEX San-Apro Limited (JP) 2007-02-14 EP disclosed
US-20050113483-A1 Actinic ray curable ink-jet ink composition, image formation method employing the same, and ink-jet recording apparatus KONICA MINOLTA MEDICAL & GRAPHIC, INC. 2005-05-26 US disclosed
EP-0927726-B1 PHOTOCATALYTIC COMPOSITION NIPPON SODA CO (JP) 2004-11-10 EP disclosed
EP-1201638-B1 PHOTOCURABLE COMPOSITION CONTAINING IODONIUM SALT COMPOUND NIPPON SODA CO (JP) 2004-06-23 EP disclosed
US-6677390-B1 CURABLE MIXTURES COMPRISING SENSITIZERS AND HALOGEN COMPOUNDS SUCH AS 4-CARBOXYMETHOXYPHENYL-2',4',6'-TRIMETHYLPHENYL-IODONIUM HEXAFLUOROPHOSPHATE, USED AS NONTOXIC ACID GENERATORS OR CATALYSTS; QUICK SETTING NIPPON SODA CO., LTD. (JP) 2004-01-13 US disclosed
US-6558871-B1 Photopolymerization initiator comprising at least one of diaryliodonium salt NIPPON SODA CO. LTD. (JP) 2003-05-06 US disclosed
EP-1201638-A1 PHOTOCURABLE COMPOSITION CONTAINING IODONIUM SALT COMPOUND NIPPON SODA CO., LTD. (JP) 2002-05-02 EP disclosed
US-6313188-B1 USED AS CATALYSTS FOR CATIONIC PHOTOPOLYMERIZATION NIPPON SODA CO., LTD. (JP) 2001-11-06 US disclosed
EP-1106639-A1 PHOTOCURABLE COMPOSITION CONTAINING IODONIUM SALT COMPOUND NIPPON SODA CO., LTD. (JP) 2001-06-13 EP disclosed
EP-0927726-A1 PHOTOCATALYTIC COMPOSITION NIPPON SODA CO., LTD. (JP) 1999-07-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12624392-B2 Molecular array generation using photoresist POLL, LIG4, LIG3 ALDH1A1 189/4885KDM4E 1169/4885MAPK1 2265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.